Analyst firms · H.C. Wainwright · TARO
H.C. Wainwright TARO price target and rating history
Taro Pharmaceutical Industries Ltd. (TARO) · Health Care
H.C. Wainwright rates Taro Pharmaceutical Industries Ltd. (TARO) Neutral with a $43 price target, as of its latest action on Jan 18, 2024. It has published 4 rating actions on TARO since July 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $43
- Median target, all firms
- Too few
- Actions on TARO
- 4
H.C. Wainwright price target on TARO
Every H.C. Wainwright rating on TARO
- Jan 18, 2024
- Jan 31, 2022
- Jan 18, 2022
- Jul 28, 2021
Questions about H.C. Wainwright and TARO
- What is H.C. Wainwright's price target for TARO?
- H.C. Wainwright's latest stated price target for Taro Pharmaceutical Industries Ltd. (TARO) is $43, from its action on Jan 18, 2024.
- What is H.C. Wainwright's rating on TARO?
- H.C. Wainwright rates TARO Neutral, a neutral rating, as of Jan 18, 2024.
- When did H.C. Wainwright last change its view on TARO?
- On Jan 18, 2024, H.C. Wainwright downgrades to Neutral from Buy, price target $43.
All H.C. Wainwright ratingsTARO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.